Alum’s Revolutionary Discovery Is Changing Cancer Treatment
James P. Allison (B.A. '69, Ph.D. '73) was a key source for a groundbreaking series of stories in the New York Times about immunotherapy cancer treatment.
James P. Allison (B.A. '69, Ph.D. '73) was a key source for a groundbreaking series of stories in the New York Times about immunotherapy cancer treatment.
Chemistry major and retired Dupont engineer dedicates time to mentoring current black students through the Precursors, a group made of some of the first black students to attend UT in the 50s and 60s.